دورية أكاديمية
eIF3 controls cell size independently of S6K1-activity.
| العنوان: | eIF3 controls cell size independently of S6K1-activity. |
|---|---|
| المؤلفون: | Schipany K; Institute of Medical Genetics, Center of Pathobiochemistry and Genetics, Medical University of Vienna, A-1090 Vienna, Austria., Rosner M; Institute of Medical Genetics, Center of Pathobiochemistry and Genetics, Medical University of Vienna, A-1090 Vienna, Austria., Ionce L; Institute of Medical Genetics, Center of Pathobiochemistry and Genetics, Medical University of Vienna, A-1090 Vienna, Austria., Hengstschläger M; Institute of Medical Genetics, Center of Pathobiochemistry and Genetics, Medical University of Vienna, A-1090 Vienna, Austria., Kovacic B; Institute of Medical Genetics, Center of Pathobiochemistry and Genetics, Medical University of Vienna, A-1090 Vienna, Austria. |
| المصدر: | Oncotarget [Oncotarget] 2015 Sep 15; Vol. 6 (27), pp. 24361-75. |
| نوع المنشور: | Journal Article; Research Support, Non-U.S. Gov't |
| اللغة: | English |
| بيانات الدورية: | Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: Print Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: Albany, N.Y. : Impact Journals |
| مواضيع طبية MeSH: | Cell Size* , Gene Expression Regulation, Neoplastic*, Eukaryotic Initiation Factor-3/*metabolism , Ribosomal Protein S6 Kinases, 70-kDa/*metabolism, Cell Proliferation ; Cell Transformation, Neoplastic ; Enzyme Inhibitors/chemistry ; Fibroblasts/metabolism ; HEK293 Cells ; Humans ; Imidazoles/chemistry ; Mutation ; Phenotype ; Phosphorylation ; Piperazines/chemistry ; RNA, Small Interfering/metabolism ; Ribosomal Protein S6 Kinases, 70-kDa/antagonists & inhibitors ; Signal Transduction ; TOR Serine-Threonine Kinases/metabolism |
| مستخلص: | All multicellular organisms require a life-long regulation of the number and the size of cells, which build up their organs. mTOR acts as a signaling nodule for the regulation of protein synthesis and growth. To activate the translational cascade, mTOR phosphorylates S6 kinase (S6K1), which is liberated from the eIF3-complex and mobilized for activation of its downstream targets. How S6K1 regulates cell size remains unclear. Here, we challenged cell size control through S6K1 by specifically depleting its binding partner eIF3 in normal and transformed cell lines. We show that loss of eIF3 leads to a massive reduction of cell size and cell number accompanied with an unexpected increase in S6K1-activity. The hyperactive S6K1-signaling was rapamycin-sensitive, suggesting an upstream mTOR-regulation. A selective S6K1 inhibitor (PF-4708671) was unable to interfere with the reduced size, despite efficiently inhibiting S6K1-activity. Restoration of eIF3 expression recovered size defects, without affecting the p-S6 levels. We further show that two, yet uncharacterized, cancer-associated mutations in the eIF3-complex, have the capacity to recover from reduced size phenotype, suggesting a possible role for eIF3 in regulating cancer cell size. Collectively, our results uncover a role for eIF3-complex in maintenance of normal and neoplastic cell size - independent of S6K1-signaling. |
| References: | Cell. 2005 Nov 18;123(4):569-80. (PMID: 16286006) Hum Mol Genet. 2009 Sep 1;18(17):3298-310. (PMID: 19505958) Nat Methods. 2010 Apr;7(4):248-9. (PMID: 20354512) Biochem J. 2010 Oct 15;431(2):245-55. (PMID: 20704563) Nucleic Acids Res. 2015 Jan;43(Database issue):D805-11. (PMID: 25355519) Biochim Biophys Acta. 2015 Jul;1849(7):792-800. (PMID: 25450521) Nature. 2000 Dec 21-28;408(6815):994-7. (PMID: 11140689) Br J Cancer. 2001 Jun 1;84(11):1520-7. (PMID: 11384103) Genes Dev. 2002 Jun 15;16(12):1472-87. (PMID: 12080086) Biochem J. 2003 Jun 1;372(Pt 2):555-66. (PMID: 12611592) Oncogene. 2003 Jul 31;22(31):4786-98. (PMID: 12894220) Mol Cell Biol. 2004 Jan;24(1):200-16. (PMID: 14673156) Biochem Biophys Res Commun. 2004 Jan 9;313(2):429-36. (PMID: 14684180) Mol Cell Biol. 2004 Apr;24(8):3112-24. (PMID: 15060135) Oncogene. 2004 Apr 19;23(18):3151-71. (PMID: 15094765) Oncogene. 2004 Apr 19;23(18):3230-47. (PMID: 15094773) Oncogene. 2004 Apr 19;23(18):3248-64. (PMID: 15094774) Genes Dev. 2004 Aug 15;18(16):1926-45. (PMID: 15314020) Curr Biol. 2004 Sep 7;14(17):1540-9. (PMID: 15341740) Clin Cancer Res. 2009 Dec 1;15(23):7207-16. (PMID: 19934294) Blood. 2010 Mar 18;115(11):2127-35. (PMID: 20075156) Oncogene. 2011 Nov 3;30(44):4509-22. (PMID: 21602892) Science. 2011 Nov 25;334(6059):1047-8. (PMID: 22116854) Biochem J. 2012 Jan 1;441(1):1-21. (PMID: 22168436) Proc Natl Acad Sci U S A. 2011 Dec 20;108(51):20473-8. (PMID: 22135459) Cell. 2012 Apr 13;149(2):274-93. (PMID: 22500797) Curr Biol. 2012 May 8;22(9):R368-79. (PMID: 22575479) Mol Cancer Ther. 2012 Jun;11(6):1342-52. (PMID: 22496482) Nat Protoc. 2013 Mar;8(3):602-26. (PMID: 23449254) Clin Cancer Res. 2013 Jun 1;19(11):2850-60. (PMID: 23575475) Cell. 2013 Sep 12;154(6):1194-205. (PMID: 24034244) Proc Natl Acad Sci U S A. 2014 Jan 28;111(4):E435-44. (PMID: 24474794) J Biol Chem. 1989 Aug 15;264(23):13825-33. (PMID: 2760046) Cell Growth Differ. 1991 Jun;2(6):279-85. (PMID: 1648378) Curr Opin Cell Biol. 1995 Dec;7(6):806-14. (PMID: 8608011) EMBO J. 1998 Nov 16;17(22):6649-59. (PMID: 9822608) Cell. 1999 Jan 22;96(2):235-44. (PMID: 9988218) Science. 1999 Sep 24;285(5436):2126-9. (PMID: 10497130) Nat Cell Biol. 2005 Mar;7(3):286-94. (PMID: 15723049) J Neuroendocrinol. 2015 Jan;27(1):20-32. (PMID: 25323047) Nat Commun. 2014;5:4767. (PMID: 25182477) J Biol Chem. 1988 Aug 15;263(23):11473-7. (PMID: 3403539) Trends Biochem Sci. 2006 Jun;31(6):342-8. (PMID: 16679021) Nat Rev Genet. 2006 Dec;7(12):907-16. (PMID: 17139322) J Biol Chem. 2007 Feb 23;282(8):5790-800. (PMID: 17170115) EMBO J. 2007 Jul 25;26(14):3373-83. (PMID: 17581632) Nat Rev Cancer. 2010 Apr;10(4):254-66. (PMID: 20332778) |
| فهرسة مساهمة: | Keywords: S6K; cancer; cell size; eIF3; mTOR |
| المشرفين على المادة: | 0 (Enzyme Inhibitors) 0 (Eukaryotic Initiation Factor-3) 0 (Imidazoles) 0 (PF-4708671) 0 (Piperazines) 0 (RNA, Small Interfering) EC 2.7.1.1 (MTOR protein, human) EC 2.7.11.1 (Ribosomal Protein S6 Kinases, 70-kDa) EC 2.7.11.1 (TOR Serine-Threonine Kinases) EC 2.7.11.1 (ribosomal protein S6 kinase, 70kD, polypeptide 1) |
| تواريخ الأحداث: | Date Created: 20150715 Date Completed: 20160810 Latest Revision: 20211203 |
| رمز التحديث: | 20221213 |
| مُعرف محوري في PubMed: | PMC4695191 |
| DOI: | 10.18632/oncotarget.4458 |
| PMID: | 26172298 |
| قاعدة البيانات: | MEDLINE |
| تدمد: | 1949-2553 |
|---|---|
| DOI: | 10.18632/oncotarget.4458 |